Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Assets (2020 - 2023)

Historic Return on Assets for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to 0.32%.

  • ADC Therapeutics' Return on Assets fell 500.0% to 0.32% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.32%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.0% for FY2022, which is N/A changed from last year.
  • Per ADC Therapeutics' latest filing, its Return on Assets stood at 0.32% for Q3 2023, which was down 500.0% from 0.33% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Assets ranged from a high of 0.26% in Q3 2022 and a low of 424.39% during Q3 2020
  • Its 4-year average for Return on Assets is 35.74%, with a median of 0.34% in 2021.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 4240000bps in 2021, then tumbled by -700bps in 2023.
  • Over the past 4 years, ADC Therapeutics' Return on Assets (Quarter) stood at 424.39% in 2020, then skyrocketed by 100bps to 0.34% in 2021, then grew by 22bps to 0.27% in 2022, then fell by -17bps to 0.32% in 2023.
  • Its Return on Assets stands at 0.32% for Q3 2023, versus 0.33% for Q2 2023 and 0.37% for Q1 2023.